Literature DB >> 16820785

Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.

P Evenepoel1, B Bammens, K Verbeke, Y Vanrenterghem.   

Abstract

Both residual renal and dialytic clearance confer to the total solute clearance in dialysis patients. Dialytic clearances of the middle molecule beta-microglobulin (beta(2)M) and the protein-bound solute p-cresol (pcr) are generally believed to be higher with peritoneal dialysis (PD) as compared to hemodialysis (HD). Supportive data, however, are lacking. We performed a single-center cross-sectional observational study including 70 unselected patients treated with either high-flux HD (n=20) or PD (n=50). Mid-day serum levels (PD) and time-averaged concentrations (HD) of the water-soluble solutes urea nitrogen, creatinine and phosphate, the middle molecule beta(2)M, and the protein-bound solute pcr were determined. Dialytic solute clearances (l/week/1.73 m(2)) were calculated from total dialysate collection during the mid-week session in HD and 24 h dialysate collection in PD. Renal clearances were calculated for each of the respective solutes from a timed urine collection. Total clearances were obtained by summation. HD delivered significantly higher clearances of all retention solutes studied. This superiority was especially pronounced for pcr (30.9+/-62.7 vs 4.4+/-2.3, HD vs PD, P<0.0001) and beta(2)M (28.6+/-6.6 vs 5.8+/-3.1, HD vs PD, P<0.0001). Renal clearances, conversely, were significantly higher in patients on PD. Serum levels of all solutes but pcr were significantly lower in HD than in PD. Both a higher residual renal function and a lower generation rate contribute to the lower pcr levels in PD. In conclusion, superior dialytic clearance of both water-soluble solutes, beta(2)M, and pcr is achieved by high-flux HD as compared to PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820785     DOI: 10.1038/sj.ki.5001640

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Acute kidney injury: are we biased against peritoneal dialysis?

Authors:  Sérgio Gaião; Fredric O Finkelstein; Massimo de Cal; Claudio Ronco; Dinna N Cruz
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

2.  Contribution of residual function to removal of protein-bound solutes in hemodialysis.

Authors:  Ilian O Marquez; Shouieb Tambra; Frank Y Luo; You Li; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

3.  Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?

Authors:  Raymond Vanholder; Natalie Meert; Wim Van Biesen; Timothy Meyer; Thomas Hostetter; Annemieke Dhondt; Sunny Eloot
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

4.  Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Authors:  Liesbeth Viaene; Björn K I Meijers; Bert Bammens; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Perit Dial Int       Date:  2013-10-31       Impact factor: 1.756

Review 5.  Once upon a time in dialysis: the last days of Kt/V?

Authors:  Raymond Vanholder; Griet Glorieux; Sunny Eloot
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

Review 6.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

7.  Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

Authors:  Sunil V Badve; Deborah L Zimmerman; Greg A Knoll; Kevin D Burns; Brendan B McCormick
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

8.  White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.

Authors:  Caroline C Pelletier; Laetitia Koppe; Marine L Croze; Emilie Kalbacher; Roxane E Vella; Fitsum Guebre-Egziabher; Alain Géloën; Lionel Badet; Denis Fouque; Christophe O Soulage
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

9.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Authors:  Björn K I Meijers; Henriette De Loor; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

10.  Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Authors:  Joon-Sung Park; Gheun-Ho Kim; Chong Myung Kang; Chang Hwa Lee
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.